"adenocarcinoma colorectal cancer" trang 12 - tải miễn phí từ tailieunhanh
Survival benefit of pembrolizumab for patients with pancreatic adenocarcinoma: A case series

Survival benefit of pembrolizumab for patients with pancreatic adenocarcinoma: A case series
4    1    1
A presentation of synchronous ovarian and endometrial endometrioid adenocarcinoma from a case of suspected ruptured ectopic pregnancy

A presentation of synchronous ovarian and endometrial endometrioid adenocarcinoma from a case of suspected ruptured ectopic pregnancy
5    8    1
The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma

The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma
15    1    1
High NANOG expression correlates with worse patients’ survival in esophageal adenocarcinoma

High NANOG expression correlates with worse patients’ survival in esophageal adenocarcinoma
9    1    1
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma

A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
12    1    1
Randomised phase II trial of trifuridine/ tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifuridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)

Randomised phase II trial of trifuridine/ tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifuridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)
8    1    1
Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infltration in lung adenocarcinoma

Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infltration in lung adenocarcinoma
21    1    1
Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients

Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients
20    1    1
TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway

TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway
12    1    1
MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma

MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma
11    1    1
Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma

Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma
12    5    1
CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling

CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling
12    2    1
Identification of four metabolic subtypes and key prognostic markers in lung adenocarcinoma based on glycolytic and glutaminolytic pathways

Identification of four metabolic subtypes and key prognostic markers in lung adenocarcinoma based on glycolytic and glutaminolytic pathways
15    2    1
Integrated transcriptional analysis reveals macrophage heterogeneity and macrophagetumor cell interactions in the progression of pancreatic ductal adenocarcinoma

Integrated transcriptional analysis reveals macrophage heterogeneity and macrophagetumor cell interactions in the progression of pancreatic ductal adenocarcinoma
14    4    1
Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma

Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma
14    4    1
A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma

A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma
17    2    1
Application value of Ki67 and serum CA125 in the deep myometrial invasion of endometrial adenocarcinoma

Application value of Ki67 and serum CA125 in the deep myometrial invasion of endometrial adenocarcinoma
6    5    1
Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma

Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma
10    4    1
Radiomics nomogram for preoperative differentiation of pulmonary mucinous adenocarcinoma from tuberculoma in solitary pulmonary solid nodules

Radiomics nomogram for preoperative differentiation of pulmonary mucinous adenocarcinoma from tuberculoma in solitary pulmonary solid nodules
11    2    1
CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma

CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
13    10    1